Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
Key points are not available for this paper at this time.
Abstract
International audience
AI에게 질문
Like
Bookmark
Share
View Full Paper
AI에게 질문
Like
Bookmark
Share
View Full Paper
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations | Synapse